Argan, Inc. (NYSE Alternext U.S.: AGX) today announced financial
results for the three and nine months ended October 31, 2008.
For the nine months ended October 31, 2008, net revenues were $164.9
million compared to $152.8 million in the nine months ended October 31,
2007. Gemma contributed $151.0 million, or 91.6% of total revenues, in
the first nine months of fiscal 2009 compared to $131.0 million, or
85.7% of total revenues in the first nine months of fiscal 2008.
Combined revenues from Argan’s other wholly-owned subsidiaries decreased
to $13.9 million, or 8.4% of total revenues in the first nine months of
fiscal 2009 compared to $21.9 million, or 14.3% of total revenues in the
first nine months of fiscal 2008. Net income for the first nine months
ended October 31, 2008 was $5.0 million, or $0.40 per fully diluted
share based on 12,480,000 fully diluted shares outstanding compared to a
net loss of $2.6 million or ($0.24) per fully diluted share based on
11,095,000 fully diluted shares outstanding for the first nine months
ended October 31, 2007.
Net revenues for the three months ended October 31, 2008 were $41.4
million compared to $49.3 million for the three months ended October 31,
2007. Argan’s wholly-owned subsidiary, Gemma Power Systems (Gemma),
contributed $36.4 million, or 87.9% of total revenues, for the quarter
ended October 31, 2008 compared to $42.0 million, or 85.3% of total
revenues, for the quarter ended October 31, 2007. Combined revenues for
the quarter ended October 31, 2008 at Argan’s other wholly-owned
subsidiaries decreased to $5.0 million or 12.1% of total revenues from
$7.2 million, or 14.7% of total revenues, in the quarter ended October
31, 2007. Net income for the third quarter ended October 31, 2008 was
$2.6 million, or $0.19 per fully diluted share based on 13,730,000 fully
diluted shares outstanding compared to a net loss of $2.0 million, or
($0.18) per fully diluted share based on 11,096,000 fully diluted shares
outstanding in the quarter ended October 31, 2007.
The Company reported consolidated EBITDA (Earnings before interest,
taxes, depreciation and amortization) of $13.3 million and $4.5 million,
respectively, for the nine months and three months ended October 31,
2008.
On a segment basis, Gemma reported income before income taxes of $16
million for the nine months and $5.9 million for the three months ended
October 31, 2008.
Argan had cash of $93.1 million and escrowed cash of $10.3 as of October
31, 2008. The Company’s backlog as of October 31, 2008 was $505 million.
Included in the backlog is Gemma’s engineering, procurement and
construction agreement with Competitive Power Ventures (CPV), signed in
October and valued at $211 million, to design and build eight simple
cycle gas-fired peaking plants with a total power rating of 800
megawatts, to be located in southern California. Additionally in the
three months ended October 31, 2008, Gemma received a full notice to
proceed from Pacific Gas & Electric on the design and construction of a
natural gas-fired power plant in Colusa, California. The Company
previously announced that it had signed an engineering, procurement and
construction agreement for the Colusa project.
Gemma’s backlog does not include projects associated with Gemma
Renewable Power, its business partnership with Invenergy Wind
Management. During the quarter, Gemma Renewable Power received an
initial limited notice to proceed on a project with an estimated
contract value of $50 million, to design and build the expansion of a
wind farm in LaSalle County, Illinois.
Commenting on Argan’s results, Rainer Bosselmann, Chairman and Chief
Executive Officer stated, “We achieved strong EBITDA margin and improved
net income year-to-date and for the quarter. Gemma continues to perform
very well and benefits from its reputation as a leading designer and
builder of power plants. Year-to-date revenue at Gemma increased 15% and
year-to-date pretax income increased by 147%. During the quarter, Gemma
was successfully completing the final phases of several renewable energy
projects and was in the early stages of two substantial traditional
power projects.”
Mr. Bosselmann concluded, “In addition to Gemma’s strong existing
backlog, we are encouraged by potential opportunities for the design and
construction of wind farms through Gemma Renewable Power, our joint
venture with Invenergy. Gemma has been very successful in the design and
construction of traditional energy plants and we believe that expertise
will translate well to the efficient design and development of wind
energy facilities.”
About Argan, Inc.
Argan’s primary business is designing and building energy plants through
its Gemma Power Systems subsidiary. These energy plants include
traditional gas as well as alternative energy including biodiesel,
ethanol, and renewable energy sources such as wind power and solar.
Argan also owns Southern Maryland Cable, Inc. and Vitarich Laboratories,
Inc.
Certain matters discussed in this press release may constitute
forward-looking statements within the meaning of the federal securities
laws and are subject to risks and uncertainties including, but not
limited to; (1) the Company’s ability to achieve its business strategy
while effectively managing costs and expenses; (2) the Company’s ability
to successfully and profitably integrate acquisitions; and (3) the
continued strong performance of the energy sector. Actual results and
the timing of certain events could differ materially from those
projected in or contemplated by the forward-looking statements due to a
number of factors detailed from time to time in Argan’s filings with the
Securities and Exchange Commission. In addition, reference is
hereby made to cautionary statements with respect to risk factors set
forth in the Company’s most recent reports on Form 10-K and 10-Q, and
other SEC filings.
|
|
|
|
|
|
|
ARGAN, INC. AND SUBSIDIARIES
|
|
Consolidated Statements of Operations
|
|
|
|
|
|
|
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
Net revenues
|
|
|
|
|
|
|
|
|
|
Power industry services
|
|
$
|
36,387,000
|
|
|
$
|
42,017,000
|
|
|
$
|
151,034,000
|
|
|
$
|
130,970,000
|
|
|
Nutritional products
|
|
|
2,662,000
|
|
|
|
4,617,000
|
|
|
|
7,287,000
|
|
|
|
14,602,000
|
|
|
Telecommunication infrastructure services
|
|
|
2,338,000
|
|
|
|
2,629,000
|
|
|
|
6,570,000
|
|
|
|
7,260,000
|
|
|
Net revenues
|
|
|
41,387,000
|
|
|
|
49,263,000
|
|
|
|
164,891,000
|
|
|
|
152,832,000
|
|
|
Cost of revenues
|
|
|
|
|
|
|
|
|
|
Power industry services
|
|
|
29,742,000
|
|
|
|
35,548,000
|
|
|
|
131,425,000
|
|
|
|
119,383,000
|
|
|
Nutritional products
|
|
|
2,983,000
|
|
|
|
4,193,000
|
|
|
|
7,701,000
|
|
|
|
12,481,000
|
|
|
Telecommunication infrastructure services
|
|
|
1,824,000
|
|
|
|
2,076,000
|
|
|
|
5,474,000
|
|
|
|
5,776,000
|
|
|
Cost of revenues
|
|
|
34,549,000
|
|
|
|
41,817,000
|
|
|
|
144,600,000
|
|
|
|
137,640,000
|
|
|
Gross profit
|
|
|
6,838,000
|
|
|
|
7,446,000
|
|
|
|
20,291,000
|
|
|
|
15,192,000
|
|
|
Selling, general and administrative expenses
|
|
|
3,090,000
|
|
|
|
4,381,000
|
|
|
|
11,118,000
|
|
|
|
13,715,000
|
|
|
Impairment losses of VLI
|
|
|
--
|
|
|
|
4,666,000
|
|
|
|
1,946,000
|
|
|
|
4,666,000
|
|
|
Income (loss) from operations
|
|
|
3,748,000
|
|
|
|
(1,601,000
|
)
|
|
|
7,227,000
|
|
|
|
(3,189,000
|
)
|
|
Other income, net
|
|
|
306,000
|
|
|
|
903,000
|
|
|
|
850,000
|
|
|
|
1,802,000
|
|
|
Income (loss) from operations before income taxes
|
|
|
4,054,000
|
|
|
|
(698,000
|
)
|
|
|
8,077,000
|
|
|
|
(1,387,000
|
)
|
|
Income tax expense
|
|
|
(1,430,000
|
)
|
|
|
(1,259,000
|
)
|
|
|
(3,092,000
|
)
|
|
|
(1,253,000
|
)
|
|
Net income (loss)
|
|
$
|
2,624,000
|
|
|
$
|
(1,957,000
|
)
|
|
$
|
4,985,000
|
|
|
$
|
(2,640,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.20
|
|
|
$
|
(0.18
|
)
|
|
$
|
0.41
|
|
|
$
|
(0.24
|
)
|
|
Diluted
|
|
$
|
0.19
|
|
|
$
|
(0.18
|
)
|
|
$
|
0.40
|
|
|
$
|
(0.24
|
)
|
|
Weighted average number of shares outstanding:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
13,414,000
|
|
|
|
11,096,000
|
|
|
|
12,138,000
|
|
|
|
11,095,000
|
|
|
Diluted
|
|
|
13,730,000
|
|
|
|
11,096,000
|
|
|
|
12,480,000
|
|
|
|
11,095,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliations to EBITDA
|
|
|
|
|
|
|
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss), as reported
|
|
$
|
2,624,000
|
|
$
|
(1,957,000
|
)
|
|
$
|
4,985,000
|
|
$
|
(2,640,000
|
)
|
|
Income tax expense
|
|
|
1,430,000
|
|
|
1,259,000
|
|
|
|
3,092,000
|
|
|
1,253,000
|
|
|
Depreciation and other amortization
|
|
|
159,000
|
|
|
324,000
|
|
|
|
842,000
|
|
|
968,000
|
|
|
Amortization of purchased intangible assets
|
|
|
115,000
|
|
|
1,201,000
|
|
|
|
1,289,000
|
|
|
5,290,000
|
|
|
Interest expense
|
|
|
108,000
|
|
|
171,000
|
|
|
|
336,000
|
|
|
550,000
|
|
|
Stock option compensation expense
|
|
|
60,000
|
|
|
182,000
|
|
|
|
848,000
|
|
|
282,000
|
|
|
Impairment losses of VLI
|
|
|
--
|
|
|
4,666,000
|
|
|
|
1,946,000
|
|
|
4,666,000
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
4,496,000
|
|
$
|
5,846,000
|
|
|
$
|
13,338,000
|
|
$
|
10,369,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management uses EBITDA, a non-GAAP financial measure, for planning
purposes, including the preparation of operating budgets and to
determine appropriate levels of operating and capital investments.
Management believes that EBITDA provides additional insight for
analysts and investors in evaluating the Company's financial and
operational performance and in assisting investors in comparing the
Company's financial performance to those of other companies in the
Company's industry. However, EBITDA is not intended to be an
alternative to financial measures prepared in accordance with GAAP
and should not be considered in isolation from our GAAP results of
operations. Pursuant to the requirements of SEC Regulation G,
reconciliations between the Company's GAAP and non-GAAP financial
results are provided above and investors are advised to carefully
review and consider this information as well as the GAAP financial
results that are disclosed in the Company's SEC filings.
|
|
|
|
|
|
|
|
|
|
ARGAN, INC. AND SUBSIDIARIES
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
October 31,
|
|
January 31,
|
|
ASSETS
|
|
2008
|
|
2008
|
|
CURRENT ASSETS:
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
93,143,000
|
|
|
$
|
66,827,000
|
|
|
Escrowed cash
|
|
|
10,324,000
|
|
|
|
14,398,000
|
|
|
Accounts receivable, net of allowance for doubtful accounts
|
|
|
3,420,000
|
|
|
|
30,481,000
|
|
|
Inventories, net of reserve for obsolescence
|
|
|
2,533,000
|
|
|
|
2,808,000
|
|
|
Current deferred tax assets
|
|
|
882,000
|
|
|
|
406,000
|
|
|
Prepaid expenses and other current assets
|
|
|
1,383,000
|
|
|
|
1,330,000
|
|
|
TOTAL CURRENT ASSETS
|
|
|
111,685,000
|
|
|
|
116,250,000
|
|
|
Property and equipment, net of accumulated depreciation
|
|
|
1,331,000
|
|
|
|
2,892,000
|
|
|
Goodwill
|
|
|
19,416,000
|
|
|
|
20,337,000
|
|
|
Other purchased intangible assets, net of accumulated amortization
|
|
|
3,921,000
|
|
|
|
5,296,000
|
|
|
Investment in unconsolidated subsidiary
|
|
|
1,241,000
|
|
|
|
--
|
|
|
Deferred tax assets
|
|
|
2,321,000
|
|
|
|
828,000
|
|
|
Other assets
|
|
|
153,000
|
|
|
|
260,000
|
|
|
TOTAL ASSETS
|
|
$
|
140,068,000
|
|
|
$
|
145,863,000
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
Accounts payable
|
|
$
|
29,853,000
|
|
|
$
|
35,483,000
|
|
|
Accrued expenses
|
|
|
9,142,000
|
|
|
|
9,370,000
|
|
|
Billings in excess of cost and earnings
|
|
|
22,557,000
|
|
|
|
52,313,000
|
|
|
Current portion of long-term debt
|
|
|
2,526,000
|
|
|
|
2,581,000
|
|
|
TOTAL CURRENT LIABILITIES
|
|
|
64,078,000
|
|
|
|
99,747,000
|
|
|
Long-term debt
|
|
|
2,250,000
|
|
|
|
4,134,000
|
|
|
Other liabilities
|
|
|
77,000
|
|
|
|
116,000
|
|
|
TOTAL LIABILITIES
|
|
|
66,405,000
|
|
|
|
103,997,000
|
|
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
Preferred stock, par value $0.10 per share; 500,000 shares
authorized; no shares issued and outstanding
|
|
|
--
|
|
|
|
--
|
|
|
Common stock, par value $0.15 per share; 30,000,000 shares
authorized; 13,433,684 and 11,113,534 shares issued at
10/31/08 and 1/31/08, and 13,430,451 and 11,110,301 shares
outstanding at 10/31/08 and 1/31/08, respectively
|
|
|
2,014,000
|
|
|
|
1,667,000
|
|
|
Warrants outstanding
|
|
|
753,000
|
|
|
|
834,000
|
|
|
Additional paid-in capital
|
|
|
84,359,000
|
|
|
|
57,861,000
|
|
|
Accumulated other comprehensive loss
|
|
|
(59,000
|
)
|
|
|
(107,000
|
)
|
|
Accumulated deficit
|
|
|
(13,371,000
|
)
|
|
|
(18,356,000
|
)
|
|
Treasury stock, at cost; 3,233 shares at 10/31/08 and 1/31/08
|
|
|
(33,000
|
)
|
|
|
(33,000
|
)
|
|
TOTAL STOCKHOLDERS' EQUITY
|
|
|
73,663,000
|
|
|
|
41,866,000
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
140,068,000
|
|
|
$
|
145,863,000
|
|
|
|
|
|
|
|
Argan, Inc.
Rainer Bosselmann/Arthur Trudel
301-315-0027
or
Investor
Relations:
Institutional Marketing Services (IMS)
John
Nesbett/Jennifer Belodeau
203-972-9200